A surge in norovirus infections this season has resulted in a 28% positivity rate, more than double 2024's high, alarming health officials, CBS News reported Jan. 14.
COVID-19 Phase 2b study poised to initiate 10,000 participant portion of trial pending U.S. Food and Drug Administration (FDA) review of sentinel cohort 30-day safety data Norovirus program to proceed ...
Results that may be inaccessible to you are currently showing.